1、Annual Report2022KEY FIGURES 2022Merck GroupNet sales millionMerck GroupMerck GroupEBITDA pre1 million1 Not defined by International Financial Reporting Standards(IFRS).Change million20222021 million%Net sales22,23219,6872,54612.9%Operating result(EBIT)14,4744,1792967.1%Margin(%of net sales)120.1%21
2、.2%EBITDA26,5045,9465589.4%Margin(%of net sales)129.3%30.2%EBITDA pre 16,8496,10374612.2%Margin(%of net sales)130.8%31.0%Profit after tax3,3393,0652748.9%Earnings per share(in)7.657.030.628.8%Earnings per share pre()110.058.721.3315.3%Operating cash flow 4,2594,616-357-7.7%1 Not defined by Internati
3、onal Financial Reporting Standards(IFRS).2 Not defined by International Financial Reporting Standards(IFRS);EBITDA corresponds to operating result(EBIT)adjusted by depreciation,amortization,impairment losses,and reversals of impairment losses.AT A GLaNCEA strong teamLife Science Together,we impact l
4、ife and health with science.Net sales per regionHealthcare We help to create,im-prove and prolong lives.ElectronicsWe are advancing digital living.employees64,243Share ofnet sales47%Share ofnet sales35%Share ofnet sales18%Share ofEBITDA pre51%Share ofEBITDA pre33%Share ofEBITDA pre16%nationalities13
5、9women in leadership positions38%Asia-Pacific 7,697 millionEurope 6,248 millionNorth America 6,361 millionLatin America 1,231 millionMiddle East and Africa 695 million To our shareholders 6 Letter from Beln Garijo 10 The Executive Board 11 Merck Shares Combined Management Report 15 Fundamental Infor
6、mation about the Group 15 Merck 25 Strategy 31 Internal Management System 38 Research and Development 50 Report on Economic Position 50 Macroeconomic and Sector-Specific Environment 54 Review of Forecast against Actual Business Development 61 Course of Business and Economic Position 61 Merck Group 7